Tandem Diabetes Care, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Tandem Diabetes Care, Inc. (TNDM) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $3.45 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-02-19
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $3.45M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $16.15M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $11.70M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $30.24M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-12-31 | $3.45M 10-K · filed 2026-02-19 |
| 2024-12-31 | $16.15M 10-K · filed 2026-02-19 |
| 2023-12-31 | $11.70M 10-K · filed 2026-02-19 |
| 2022-12-31 | $30.24M 10-K · filed 2026-02-19 |
| 2021-12-31 | $452.08M 10-K · filed 2025-02-26 |
| 2020-12-31 | $268.65M 10-K · filed 2024-02-21 |
| 2019-12-31 | $181.41M 10-K · filed 2023-02-22 |
| 2018-12-31 | $116.99M 10-K · filed 2021-02-24 |
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 |
| 2016-12-31 | $1.59M 10-K · filed 2019-02-26 |
| 2015-12-31 | $19.16M 10-K · filed 2018-03-01 |
| 2014-12-31 | $23.53M 10-K · filed 2017-03-08 |
| 2013-12-31 | $80.37M 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |